These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

722 related items for PubMed ID: 2509347

  • 21. Analysis of DNA adducts in smokers' lung and urothelium by 32P-postlabelling: metabolic phenotype dependence and comparisons with other exposure markers.
    Bartsch H, Castegnaro M, Camus AM, Schouft A, Geneste O, Rojas M, Alexandrov K.
    IARC Sci Publ; 1993; (124):331-40. PubMed ID: 8225503
    [Abstract] [Full Text] [Related]

  • 22. Synthesis, characterization, and 32P-postlabeling of N-(deoxyguanosin)-4-aminobiphenyl 3'-phosphate adducts.
    Haack T, Boche G, Kliem C, Wiessler M, Albert D, Schmeiser HH.
    Chem Res Toxicol; 2004 Jun; 17(6):776-84. PubMed ID: 15206898
    [Abstract] [Full Text] [Related]

  • 23. DNA adducts in tumour, normal peripheral lung and bronchus, and peripheral blood lymphocytes from smoking and non-smoking lung cancer patients: correlations between tissues and detection by 32P-postlabelling and immunoassay.
    Gyorffy E, Anna L, Gyori Z, Segesdi J, Minárovits J, Soltész I, Kostic S, Csekeo A, Poirier MC, Schoket B.
    Carcinogenesis; 2004 Jul; 25(7):1201-9. PubMed ID: 15001535
    [Abstract] [Full Text] [Related]

  • 24. Recovery of bulky DNA adducts by the regular and a modified 32P-postlabelling assay; influence of the DNA-isolation method.
    Kovács K, Anna L, Rudnai P, Schoket B.
    Mutat Res; 2011 Mar 18; 721(1):95-100. PubMed ID: 21237286
    [Abstract] [Full Text] [Related]

  • 25. Detection and characterization of carcinogen-DNA adducts in exfoliated urothelial cells from 4-aminobiphenyl-treated dogs by 32P-postlabelling and subsequent thin-layer and high-pressure liquid chromatography.
    Talaska G, Dooley KL, Kadlubar FF.
    Carcinogenesis; 1990 Apr 18; 11(4):639-46. PubMed ID: 2323002
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Aromatic DNA adducts in white blood cells of foundry workers.
    Hemminki K, Perera FP, Phillips DH, Randerath K, Reddy MV, Santella RM.
    IARC Sci Publ; 1988 Apr 18; (89):190-5. PubMed ID: 3143668
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. 32P-post-labelling analysis of DNA adducts formed in the livers of animals treated with safrole, estragole and other naturally-occurring alkenylbenzenes. I. Adult female CD-1 mice.
    Randerath K, Haglund RE, Phillips DH, Reddy MV.
    Carcinogenesis; 1984 Dec 18; 5(12):1613-22. PubMed ID: 6499112
    [Abstract] [Full Text] [Related]

  • 31. Age-, tissue-, and Ah genotype-dependent differences in the binding of 3-methylcholanthrene and its metabolite(s) to mouse DNA.
    Lu LJ, Harvey RG, Lee H, Baxter JR, Anderson LM.
    Cancer Res; 1990 Jul 15; 50(14):4239-47. PubMed ID: 2364382
    [Abstract] [Full Text] [Related]

  • 32. Detection of carcinogen-DNA adducts in exfoliated urothelial cells of cigarette smokers: association with smoking, hemoglobin adducts, and urinary mutagenicity.
    Talaska G, Schamer M, Skipper P, Tannenbaum S, Caporaso N, Unruh L, Kadlubar FF, Bartsch H, Malaveille C, Vineis P.
    Cancer Epidemiol Biomarkers Prev; 1991 Jul 15; 1(1):61-6. PubMed ID: 1845172
    [Abstract] [Full Text] [Related]

  • 33. 32P-postlabeling assay for carcinogen-DNA adducts and other dna modifications.
    Randerath K, Randerath E.
    J UOEH; 1989 Mar 20; 11 Suppl():368-86. PubMed ID: 2664950
    [Abstract] [Full Text] [Related]

  • 34. Detection of DNA modifications by the 32P-postlabelling assay.
    Phillips DH.
    Mutat Res; 1997 Aug 01; 378(1-2):1-12. PubMed ID: 9288880
    [Abstract] [Full Text] [Related]

  • 35. Characterization of DNA adducts formed by aristolochic acids in the target organ (forestomach) of rats by 32P-postlabelling analysis using different chromatographic procedures.
    Stiborová M, Fernando RC, Schmeiser HH, Frei E, Pfau W, Wiessler M.
    Carcinogenesis; 1994 Jun 01; 15(6):1187-92. PubMed ID: 8020154
    [Abstract] [Full Text] [Related]

  • 36. ³²P-postlabelling for the sensitive detection of DNA adducts.
    Jones NJ.
    Methods Mol Biol; 2012 Jun 01; 817():183-206. PubMed ID: 22147574
    [Abstract] [Full Text] [Related]

  • 37. Enzyme-mediated phosphorylation of polycyclic hydrocarbon metabolites: detection of non-adduct compounds in the 32P-postlabelling assay.
    Masento MS, Hewer A, Grover PL, Phillips DH.
    Carcinogenesis; 1989 Aug 01; 10(8):1557-9. PubMed ID: 2665969
    [Abstract] [Full Text] [Related]

  • 38. 32P-postlabeling assay for carcinogen-DNA adducts: nuclease P1-mediated enhancement of its sensitivity and applications.
    Reddy MV, Randerath K.
    Environ Health Perspect; 1987 Dec 01; 76():41-7. PubMed ID: 2834194
    [Abstract] [Full Text] [Related]

  • 39. 32P-adduct assay: comparative recoveries of structurally diverse DNA adducts in the various enhancement procedures.
    Gupta RC, Earley K.
    Carcinogenesis; 1988 Sep 01; 9(9):1687-93. PubMed ID: 3409474
    [Abstract] [Full Text] [Related]

  • 40. High-performance liquid chromatographic analysis of 32P-postlabeled DNA-aromatic carcinogen adducts.
    Levy GN, Weber WW.
    Anal Biochem; 1988 Nov 01; 174(2):381-92. PubMed ID: 3239743
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 37.